Novo Nordisk
NVO
NVO
537 hedge funds and large institutions have $7.57B invested in Novo Nordisk in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 151 increasing their positions, 192 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less repeat investments, than reductions
Existing positions increased: 151 | Existing positions reduced: 192
21% less funds holding in top 10
Funds holding in top 10: 14 → 11 (-3)
23% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 52
Holders
537
Holding in Top 10
11
Calls
$77.7M
Puts
$58.3M
Top Buyers
| 1 | +$94.6M | |
| 2 | +$34.7M | |
| 3 | +$32.3M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$26.1M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$21.1M |
Top Sellers
| 1 | -$125M | |
| 2 | -$69.8M | |
| 3 | -$69.5M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$34.1M |
| 5 |
BlackRock
New York
|
-$27.6M |